Design, development, and evaluation of a novel microneedle array-based continuous glucose monitor

Journal of Diabetes Science and Technology

Volumn 8, Issue 3, 2014, Pages 483-487

  Jina, Arvind ^a   Tierney, Michael J ^a   Tamada, Janet A ^a   McGill, Scott ^a   Desai, Shashi ^a   Chua, Beelee ^a   Chang, Anna ^b   Christiansen, Mark ^c  

^a ArKal Medical Inc   (United States)

^b John Muir Physician Network Clinical Research Center   (United States)

^c Diablo Clinical Research   (United States)

Author keywords

Continuous glucose; Interstitial fluid; Microneedle; Minimally invasive

Indexed keywords

GLUCOSE; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ACCURACY; ADULT; AGED; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; ARTICLE; BLOOD GLUCOSE METER; CLINICAL ARTICLE; CLINICAL STUDY; CONTINUOUS GLUCOSE MONITOR; DIABETIC PATIENT; DIFFUSION; ELECTRODE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL FLUID; MALE; MICRONEEDLE; MONITOR; BLOOD; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DEVICES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; EXTRACELLULAR FLUID; GENETIC PROCEDURES; MATERIALS TESTING; METABOLISM; MIDDLE AGED; MINIATURIZATION; NEEDLE; PREDICTIVE VALUE; REPRODUCIBILITY; TIME FACTOR;

ADULT; AGED; BIOMARKERS; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; EXTRACELLULAR FLUID; FEMALE; HUMANS; MALE; MATERIALS TESTING; MIDDLE AGED; MINIATURIZATION; NEEDLES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84900794678     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814526191     Document Type: Article

References (15)

1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-1476.
2. DirecNet Study Group. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatr Diabetes. 2009;10(2):91-96.
3. Hermanides J, Phillip M, DeVries JH. Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons. Diabetes Care. 2011;34(S2):S197-S201.
4. Hover CG, Stedeford T, Vigneulle RM. The development of minimally invasive continuous metabolic monitoring technologies in the U.S. Army TMM Research Program. Diabetes Tech Ther. 2005;7(1):213-224. (Pubitemid 40354591)
5. Tierney MJ, Tamada JA, Potts RO, et al. The GlucoWatch® Biographer: A frequent, automatic and non-invasive glucose monitor. Ann Med. 2000;32:632-641. (Pubitemid 32115821)
6. Wang PM, Cornwell M, Prausnitz MR. Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Tech Ther. 2005;7(1):131-141. (Pubitemid 40354583)
7. Chuang H, Taylor E, Davison TW. Clinical evaluation of a continuous minimally invasive glucose flux sensor placed over ultrasonically permeated skin. Diabetes Tech Ther. 2004;6(1):21-30. (Pubitemid 38233742)
8. Vadduraju S, Burgess DJ, Tomazos I, et al. Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Tech. 2010;4(6):1540-1562.
9. El-Laboudi A, Oliver NS, Cass A, Johnston D. Use of microneedle array devices for continuous glucose monitoring: a review. Diabetes Tech Ther. 2012;15(1):101-115.
10. Chua B, Desai SP, Tierney MJ, Tamada JA, Jina AN. Effect of microneedles shape on skin penetration and minimally invasive glucose monitoring in vivo. Sens Act A. 2013;203:373-381.
11. Cormier M, Daddona P, Johnson J, et al. Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure. US patent 7,438,926. October 21, 2008.
12. Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;83:377-390.
13. Garg SK, Voelmle M, Gottlieb PA. Time lag characterization of two continuous glucose monitoring systems. Diabetes Res Clin Pract. 2010;87:348-353.
14. Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human subjects. Clin J Pain. 2008;24(7):585-594.
15. Kulco E, Tamada JA, Reach G, Potts RO, Lesho MJ. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care. 2003;26(8):2405-2409. (Pubitemid 36993334)